Advenchen Pharmaceuticals, LLC.

1 clinical trials · Sponsor

Record	Firm	Date
Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment (NCT05363280)	Advenchen Pharmaceuticals, LLC.	2022-11-01

Every clearance here is in the API, with alerts when new ones post.